{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:00:10Z","timestamp":1766059210369,"version":"3.48.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["Grant-10.55776\/P35115"],"award-info":[{"award-number":["Grant-10.55776\/P35115"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["Grant-10.55776\/P35115"],"award-info":[{"award-number":["Grant-10.55776\/P35115"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013060","name":"European Molecular Biology Laboratory","doi-asserted-by":"publisher","award":["SAXS-1415"],"award-info":[{"award-number":["SAXS-1415"]}],"id":[{"id":"10.13039\/100013060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LM2023042"],"award-info":[{"award-number":["LM2023042"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CZ.02.01.01\/00\/23_015\/0008175"],"award-info":[{"award-number":["CZ.02.01.01\/00\/23_015\/0008175"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejps.2025.107361","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:54:56Z","timestamp":1762206896000},"page":"107361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pulmonary delivery of anti-infectives from natural sources: Development and characterization of liposomal sanggenon formulations"],"prefix":"10.1016","volume":"215","author":[{"given":"Jacqueline","family":"Schwarzinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4328-7684","authenticated-orcid":false,"given":"Gianluca","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3605-1937","authenticated-orcid":false,"given":"Timur","family":"Tropin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8067-7307","authenticated-orcid":false,"given":"Christian","family":"W\u00f6lk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-8496","authenticated-orcid":false,"given":"Clement","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-3199","authenticated-orcid":false,"given":"Sigrid","family":"Adelsberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2360-8882","authenticated-orcid":false,"given":"Gabriela","family":"H\u00e4drich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-0774","authenticated-orcid":false,"given":"Judith M.","family":"Rollinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-9270","authenticated-orcid":false,"given":"Ulrike","family":"Grienke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3625-4654","authenticated-orcid":false,"given":"Richard D.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-7122","authenticated-orcid":false,"given":"Lea Ann","family":"Dailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107361_bib0001","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2019.06.025","article-title":"Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells","volume":"307","author":"Abumanhal-Masarweh","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107361_bib0002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics17010036","article-title":"Liposomal formulations: a recent update","volume":"17","author":"Agrawal","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107361_bib0003","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10837450.2011.591803","article-title":"In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols","volume":"16","author":"Alexander","year":"2011","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2025.107361_bib0004","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/pharmrev.120.000108","article-title":"Inhaled medicines: past, present, and future","volume":"74","author":"Anderson","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2025.107361_bib0005","unstructured":"Avanti Research, 2025. Phase transition temperatures for glycerophospholipids [WWW Document]. https:\/\/avantiresearch.com\/tech-support\/physical-properties\/phase-transition-temps (accessed 6.25.25)."},{"key":"10.1016\/j.ejps.2025.107361_bib0006","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.chemphyslip.2008.11.006","article-title":"Interaction of Na2B12H11SH with dimyristoyl phosphatidylcholine liposomes","volume":"157","author":"Awad","year":"2009","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ejps.2025.107361_bib0007","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/AAC.00909-16","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 5. Oseltamivir carboxylate","volume":"60","author":"Bedor","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2025.107361_bib0008","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1107\/S160057671500254X","article-title":"Versatile sample environments and automation for biological solution X-ray scattering experiments at the P12 beamline (PETRA III, DESY)","volume":"48","author":"Blanchet","year":"2015","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107361_bib0009","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1107\/S0021889899012388","article-title":"Preparation of silver behenate coatings to provide low- to mid-angle diffraction calibration","volume":"33","author":"Blanton","year":"2000","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107361_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2210-8-8","article-title":"Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line","volume":"8","author":"Bopp","year":"2008","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.ejps.2025.107361_bib0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1107\/S0021889804029206","article-title":"X-ray scattering from unilamellar lipid vesicles","volume":"38","author":"Brzustowicz","year":"2005","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107361_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010143","article-title":"Pulmonary drug delivery and retention: a computational study to identify plausible parameters based on a coupled airway-mucus flow model","volume":"18","author":"Chakravarty","year":"2022","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejps.2025.107361_bib0013","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3390\/nano14221836","article-title":"Improvement in Curcumin\u2019s stability and release by formulation in flexible nano-liposomes","volume":"14","author":"Chen","year":"2024","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejps.2025.107361_bib0014","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.4155\/tde.13.71","article-title":"Liposomal formulations for inhalation","volume":"4","author":"Cipolla","year":"2013","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2025.107361_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/pharmaceutics11030099","article-title":"The development of oral amphotericin B to treat systemic fungal and parasitic infections: has the myth been finally realized?","volume":"11","author":"Cuddihy","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejps.2025.107361_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(02)00264-X","article-title":"A facile method of delivery of liposomes by nebulization","volume":"84","author":"Desai","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107361_bib0017","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1172\/JCI106164","article-title":"The in vivo pH of the extravascular space of the lung","volume":"48","author":"Effros","year":"1969","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejps.2025.107361_bib0018","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00232-022-00234-0","article-title":"Interdigitation-induced order and disorder in asymmetric membranes","volume":"255","author":"Frewein","year":"2022","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ejps.2025.107361_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120443","article-title":"Sanggenon C \u2013 A novel anti-enterococcal agent from Morus alba root bark","volume":"353","author":"Gafriller","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejps.2025.107361_bib0020","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1128\/AAC.02818-14","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. ciprofloxacin, moxifloxacin, and grepafloxacin","volume":"58","author":"Gontijo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2025.107361_bib0021","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1128\/AAC.02819-14","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. colistin","volume":"58","author":"Gontijo","year":"2014","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.ejps.2025.107361_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/srep27156","article-title":"Discovery of prenylated flavonoids with dual activity against influenza virus and Streptococcus pneumoniae","volume":"6","author":"Grienke","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2025.107361_bib0023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(98)00006-4","article-title":"Lipophilic drug derivatives in liposomes","volume":"165","author":"Gulati","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107361_bib0024","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/21691401.2017.1304403","article-title":"A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery","volume":"46","author":"Haghiralsadat","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.ejps.2025.107361_bib0025","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1107\/S1600576723008439","article-title":"Absolute scattering length density profile of liposome bilayers obtained by SAXS combined with GIXOS: a tool to determine model biomembrane structure","volume":"56","author":"Harvey","year":"2023","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejps.2025.107361_bib0026","unstructured":"International Organization for Standardization, 2009. ISO 10993-5:2009. Biological evaluation of medical devices \u2013 Part 5: tests for in vitro cytotoxicity."},{"key":"10.1016\/j.ejps.2025.107361_bib0027","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1198-743x.2001.00295.x","article-title":"Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters","volume":"7","author":"Jacobs","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejps.2025.107361_bib0028","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.tiv.2004.04.014","article-title":"Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure","volume":"18","author":"Kemp","year":"2004","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejps.2025.107361_bib0029","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s002800050965","article-title":"Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice","volume":"44","author":"Knight","year":"1999","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.ejps.2025.107361_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","article-title":"Mechanisms of solute release from porous hydrophilic polymers","volume":"15","author":"Korsmeyer","year":"1983","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107361_bib0031","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jcis.2023.07.152","article-title":"Drastic differences between the release kinetics of two highly related porphyrins in liposomal membranes: mTHPP and pTHPP","volume":"651","author":"Kuntsche","year":"2023","journal-title":"J. Colloid. Interface Sci."},{"key":"10.1016\/j.ejps.2025.107361_bib0032","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1021\/acs.jnatprod.2c00481","article-title":"1H NMR-based biochemometric analysis of Morus alba extracts toward a multipotent herbal anti-infective","volume":"86","author":"Langeder","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejps.2025.107361_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1193118","article-title":"Correlation of bioactive marker compounds of an orally applied Morus alba root bark extract with toxicity and efficacy in BALB\/c mice","volume":"14","author":"Langeder","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107361_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107361_bib0035","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1021\/acsptsci.4c00558","article-title":"A comparative pharmacokinetics study of orally and intranasally administered 8-nitro-1,3-benzothiazin-4-one (BTZ043) amorphous drug nanoparticles","volume":"7","author":"Li","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejps.2025.107361_bib0036","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/jamp.2008.0686","article-title":"Characterization of nebulized liposomal amikacin (Arikace\u2122) as a function of droplet size","volume":"21","author":"Li","year":"2008","journal-title":"J. Aerosol. Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107361_bib0037","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/pharmaceutics10030081","article-title":"Synthesis, structure\u2013activity relationships and in vitro toxicity profile of lactose-based fatty acid monoesters as possible drug permeability enhancers","volume":"10","author":"Lucarini","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107361_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01261-18","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 6. Aminoglycosides","volume":"62","author":"Marchand","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2025.107361_bib0039","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1128\/AAC.00411-10","article-title":"Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats","volume":"54","author":"Marchand","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2025.107361_bib0040","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1128\/AAC.00165-16","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats. 4. aztreonam","volume":"60","author":"Marchand","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2025.107361_bib0041","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1128\/AAC.01647-15","article-title":"Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 3. Tobramycin","volume":"59","author":"Marchand","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2025.107361_bib0042","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1517\/17425247.2015.995087","article-title":"Nebulizers for drug delivery to the lungs","volume":"12","author":"Martin","year":"2015","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107361_bib0043","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1021\/acsinfecdis.4c00192","article-title":"Intranasal administration of bedaquiline-loaded fucosylated liposomes provides anti-tubercular activity while reducing the potential for systemic side effects","volume":"10","author":"Marwitz","year":"2024","journal-title":"ACS. Infect. Dis."},{"key":"10.1016\/j.ejps.2025.107361_bib0044","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevE.80.021931","article-title":"Effect of cholesterol on structural and mechanical properties of membranes depends on lipid chain saturation","volume":"80","author":"Pan","year":"2009","journal-title":"Phys. Rev. E"},{"key":"10.1016\/j.ejps.2025.107361_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2019.111719","article-title":"Sanggenon D from root bark of mulberry inhibits the growth of Staphylococcus aureus by moderating the fatty acid biosynthesis system","volume":"140","author":"Pang","year":"2019","journal-title":"Ind. Crops. Prod."},{"key":"10.1016\/j.ejps.2025.107361_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120893","article-title":"Impact of simulated lung fluid components on the solubility of inhaled drugs and predicted in vivo performance","volume":"606","author":"Radivojev","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107361_bib0047","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/pharmaceutics14050989","article-title":"Formulation of amphotericin B in PEGylated liposomes for improved treatment of cutaneous leishmaniasis by parenteral and oral routes","volume":"14","author":"Ramos","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107361_bib0048","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","article-title":"A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs","volume":"5","author":"Ritger","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107361_bib0049","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acsnano.3c01664","article-title":"Amorphous drug nanoparticles for inhalation therapy of multidrug-resistant tuberculosis","volume":"17","author":"Rudolph","year":"2023","journal-title":"ACS. Nano"},{"key":"10.1016\/j.ejps.2025.107361_bib0050","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1248\/bpb1978.7.120","article-title":"Antitumor activity of lipophilic prodrugs of mitomycin C entrapped in liposome or O\/W emulsion","volume":"7","author":"Sasaki","year":"1984","journal-title":"J. Pharmacobio-dyn."},{"key":"10.1016\/j.ejps.2025.107361_bib0051","doi-asserted-by":"crossref","first-page":"14312","DOI":"10.1073\/pnas.96.25.14312","article-title":"Network formation of lipid membranes: triggering structural transitions by chain melting","volume":"96","author":"Schneider","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2025.107361_bib0052","article-title":"Biopharmaceutical profiling of anti-infective sanggenons from Morus alba root bark for inhalation administration","volume":"8","author":"Schwarzinger","year":"2024","journal-title":"Int. J. Pharm.: X"},{"key":"10.1016\/j.ejps.2025.107361_bib0053","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107361_bib0054","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1023\/A:1018994111594","article-title":"Novel taxol formulations: preparation and characterization of taxol-containing liposomes","volume":"11","author":"Sharma","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2025.107361_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910456","article-title":"Application of asymmetrical flow field-flow fractionation for characterizing the size and drug release kinetics of theranostic lipid nanovesicles","volume":"22","author":"Skupin-Mrugalska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107361_bib0056","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1021\/acs.langmuir.7b02933","article-title":"Aescin incorporation and nanodomain formation in DMPC model membranes","volume":"33","author":"Sreij","year":"2017","journal-title":"Langmuir."},{"key":"10.1016\/j.ejps.2025.107361_bib0057","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0378-5173(93)90140-B","article-title":"Cyclosporin A liposome aerosol: particle size and calculated respiratory deposition","volume":"97","author":"Waldrep","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107361_bib0058","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/acs.jnatprod.2c00843","article-title":"Identification of natural products inhibiting SARS-CoV-2 by targeting viral proteases: a combined in silico and in vitro approach","volume":"86","author":"Wasilewicz","year":"2023","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejps.2025.107361_bib0059","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.109.058102","article-title":"Lipid bilayers and membrane dynamics: insight into thickness fluctuations","volume":"109","author":"Woodka","year":"2012","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.ejps.2025.107361_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105026","article-title":"Interpreting non-linear drug diffusion data: utilizing Korsmeyer-Peppas model to study drug release from liposomes","volume":"138","author":"Wu","year":"2019","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T11:55:48Z","timestamp":1766058948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":60,"alternative-id":["S0928098725003586"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107361","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary delivery of anti-infectives from natural sources: Development and characterization of liposomal sanggenon formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107361"}}